|
Dec 1, 2017
|
IPO Prospectus
|
|
Dec 5, 2017
|
8-K announcing pricing of IPO
Sign In
to view filing content.
|
|
Dec 11, 2017
|
8-K with audited balance sheet
|
|
Dec 26, 2017
|
8-K announcing separate trading of common stock and warrants
Sign In
to view filing content.
|
|
Nov 14, 2018
|
DEF14A Definitive proxy for 2018 Annual Meeting
Sign In
to view filing content.
|
|
Oct 15, 2019
|
PRE14A Preliminary Proxy for shareholder meeting to extend charter
Sign In
to view filing content.
|
|
Oct 28, 2019
|
DEF14A Definitive proxy for shareholder meeting to extend charter
Sign In
to view filing content.
|
|
Dec 3, 2019
|
8-K with extension meeting results
Sign In
to view filing content.
|
|
Dec 9, 2019
|
8-K announcing expense advance agreement with potential target
Sign In
to view filing content.
|
|
Dec 27, 2019
|
PR announcing business combination with Gateway Casinos & Entertainment Limited
Sign In
to view filing content.
|
|
Dec 31, 2019
|
8-K with full Gateway merger agreement
Sign In
to view filing content.
|
|
Jan 6, 2020
|
8-K with conference call details
Sign In
to view filing content.
|
|
Jan 7, 2020
|
8-K with investor presentation
Sign In
to view filing content.
|
|
Jan 8, 2020
|
8-K with conference call transcript
|
|
Jan 27, 2020
|
8-K with updated investor presentation
Sign In
to view filing content.
|
|
Jan 31, 2020
|
8-K with Amendment #1 to Gateway Transaction Support Agreement
Sign In
to view filing content.
|
|
Jan 31, 2020
|
PREM14A Preliminary proxy for shareholder meeting to approve Gateway business combination
Sign In
to view filing content.
|
|
Feb 6, 2020
|
8-K announcing contribution to trust to extend
Sign In
to view filing content.
|
|
Feb 11, 2020
|
8-K with updated investor presentation
Sign In
to view filing content.
|
|
Feb 19, 2020
|
8-K with updated investor presentation
Sign In
to view filing content.
|
|
Feb 21, 2020
|
PRE14A Preliminary proxy for shareholder meeting to extend charter
Sign In
to view filing content.
|
|
Mar 3, 2020
|
DEF14A Definitive proxy for shareholder meeting to extend charter
Sign In
to view filing content.
|
|
Mar 4, 2020
|
8-K announcing contribution to trust to extend
Sign In
to view filing content.
|
|
Mar 25, 2020
|
DEFA14A with notice of change in extension meeting location
Sign In
to view filing content.
|
|
Mar 27, 2020
|
8-K announcing approval of charter extension
Sign In
to view filing content.
|
|
May 15, 2020
|
PRE14A Preliminary proxy for shareholder meeting to extend charter
Sign In
to view filing content.
|
|
Jun 2, 2020
|
DEF14A Definitive proxy for shareholder meeting to extend charter
Sign In
to view filing content.
|
|
Jun 24, 2020
|
DEF14A announcing adjournment of shareholder meeting to extend charter
Sign In
to view filing content.
|
|
Jun 30, 2020
|
8-K with extension meeting results
Sign In
to view filing content.
|
|
Jul 16, 2020
|
8-K announcing termination of Gateway Casinos & Entertainment Limited business combination
Sign In
to view filing content.
|
|
Oct 20, 2020
|
PRE14A Preliminary proxy for shareholder meeting to extend charter
Sign In
to view filing content.
|
|
Oct 30, 2020
|
PRER14A Revised preliminary proxy for shareholder meeting to extend charter
Sign In
to view filing content.
|
|
Nov 3, 2020
|
DEF14A Definitive proxy for charter extension meeting
Sign In
to view filing content.
|
|
Nov 30, 2020
|
8-K announcing charter extension
Sign In
to view filing content.
|
|
Feb 1, 2021
|
8-K announcing business combination with Ensysce Biosciences, Inc.
Sign In
to view filing content.
|
|
Feb 2, 2021
|
8-K with full Ensysce Biosciences merger agreement
Sign In
to view filing content.
|
|
Feb 2, 2021
|
8-K announcing investor call
Sign In
to view filing content.
|
|
Feb 3, 2021
|
8-K with investor presentation
Sign In
to view filing content.
|
|
Feb 4, 2021
|
8-K with conference call transcript
Sign In
to view filing content.
|
|
Mar 15, 2021
|
S-4 registration statement containing preliminary proxy for Ensysce Biosciences business combination
Sign In
to view filing content.
|
|
Apr 16, 2021
|
S-4/A Amendment #1 to registration statement containing preliminary proxy for Ensysce Biosciences business combination
Sign In
to view filing content.
|
|
Apr 29, 2021
|
8-K announcing FDA approval for Investigational New Drug
Sign In
to view filing content.
|
|
May 3, 2021
|
S-4/A Amendment #2 to registration statement containing preliminary proxy for Ensysce Biosciences business combination
Sign In
to view filing content.
|
|
Jun 1, 2021
|
8-K announcing plan to appeal NASDAQ listing determination
Sign In
to view filing content.
|
|
Jun 9, 2021
|
S-4/A Amendment #3 to registration statement containing preliminary proxy for Ensysce Biosciences business combination
Sign In
to view filing content.
|
|
Jun 11, 2021
|
8-K announcing modifications to private placement warrants with intent to treat them as equity
Sign In
to view filing content.
|
|
Jun 14, 2021
|
S-4/A Amendment #4 to registration statement containing preliminary proxy for Ensysce Biosciences business combination
Sign In
to view filing content.
|
|
Jun 16, 2021
|
424B3 Definitive proxy/prospectus for Ensysce Biosciences business transaction
Sign In
to view filing content.
|
|
Jun 29, 2021
|
8-K with Ensysce Biosciences meeting results
Sign In
to view filing content.
|
|
Jun 30, 2021
|
8-K/A with Ensysce Biosciences meeting results
Sign In
to view filing content.
|
|
Jul 1, 2021
|
8-K announcing closing of Ensysce Biosciences business combination
Sign In
to view filing content.
|
|
Jul 7, 2021
|
Super 8-K for closing of Ensysce Biosciences business combination
Sign In
to view filing content.
|
|
Aug 9, 2021
|
S-1 Post-closing registration statement
Sign In
to view filing content.
|
|
Sep 22, 2021
|
S-1/A Amendment to post-closing registration statement
Sign In
to view filing content.
|
|
Sep 23, 2021
|
EFFECT Effectiveness of post-closing registration statement
Sign In
to view filing content.
|